Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:52:52.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.7.0 and removes the older v3.6.6, indicating a newer version of the study record has been published.
    Difference
    0.1%
    Check dated 2026-09-20T00:42:05.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    New revision entry v3.6.6 was added to the history, replacing the prior v3.6.5. This reflects a minor platform update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:16.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new platform revision entry (v3.6.5) has been added to the record history, replacing the previous v3.6.4. This indicates a software/UI update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:56:46.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page history shows the latest site revision as v3.6.4, replacing the previous v3.6.3, indicating a platform update.
    Difference
    0.1%
    Check dated 2026-07-25T12:46:47.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small platform update rather than a change to the study data displayed.
    Difference
    0.1%
    Check dated 2026-07-03T23:27:15.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.